Corrigendum to “Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)” [Biomed. Pharmacother. 200 (2026), 119609] - 02/07/26

Saitong Muneekaew ^a, Aussara Panya ^{b, c}, Kritayaporn Saiprayong ^a, Koollawat Chupradit ^a, Thunchanok Nuchphongsai ^a, Pasut Sasithong ^a, Somsakul Pop Wongpalee ^d, Natthanich Boonsatit ^{b, c}, Methichit Wattanapanitch ^{a, ⁎}

^a Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicin Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 

^b Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand 

^c Cell Engineering for Cancer Therapy Research Group, Chiang Mai University, Chiang Mai 50200, Thailand 

^d Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand 

^⁎ Corresponding author.

Le texte complet de cet article est disponible en PDF.